Stock Market News1 week AbbVie reports positive results in Parkinson’s trial Investing.com
AbbVie reports positive results in Parkinson’s trial.
X23 hours AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily
X2 days AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks
X2 days AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha
X2 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks
X2 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks
X7 days Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha
X1 week AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks
X1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks
X1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks
X1 week AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch
X2 weeks Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube
X2 weeks AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha
X2 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks
X2 weeks Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance
X3 weeks Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks
X3 weeks Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead Seeking Alpha
X3 weeks AbbVie Stock Rises After Leerink Partners Upgrades Its Rating Zacks
X4 weeks AbbVie: Upgrading To ‘Strong Buy’ After Pullback Seeking Alpha
X4 weeks Trade Tracker: Jim Lebenthal buys more Abbvie YouTube
X4 weeks AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily
X4 weeks AbbVie, Nvidia Lead Friday’s Market Cap Stock Movers Investing.com
X4 weeks Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks
X4 weeks Where Will AbbVie Be in 5 Years? Yahoo Finance
X4 weeks AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in Europe Zacks
X1 month Dividend King AbbVie Just Paid Investors: Here’s How Much They Got 24/7 Wall St.
X1 month Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline Setback Zacks
X1 month AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? Zacks
X1 month Final Trades: Bitcoin, Abbvie and Baker Hughes YouTube
X1 month Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects Seeking Alpha
X1 month AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio Yahoo Finance
X1 month Final Trades: Lyft, Meta, United States Oil Fund & Abbvie YouTube
X1 month AbbVie And Pfizer: Q3 Dividend Checkup Post-Earnings Seeking Alpha
X1 month Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade) Seeking Alpha
X1 month AbbVie Stock: Keep Calm And Buy The Dip Seeking Alpha
X1 month Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily
X1 month AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials Yahoo Finance
X1 month RHHBY or ABBV: Which Is the Better Value Stock Right Now? Zacks
X1 month Analyst Report: AbbVie Inc Yahoo Finance
X1 month Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLH Yahoo Finance
X2 months Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in Focus Zacks
X2 months AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPS MarketBeat
X2 months AbbVie: 3 Positives From The Earnings Report Seeking Alpha
X2 months AbbVie Inc. (NYSE:ABBV) Short Interest Up 8.9% in October MarketBeat
X2 months AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS View Zacks
X2 months AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend Announcement MarketBeat
X2 months Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics Zacks
X2 months AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq Investing.com
X2 months AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat Investor's Business Daily
X2 months Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? Zacks
X2 months AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst Upgrade MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.